WBB Securities raises Turn Therapeutics to Hold from Sell, keeps $10 target
WBB Securities raised its rating on Turn Therapeutics to Hold from Sell, while its price target stays at $10.00 per share.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
WBB Securities raised its rating on Turn Therapeutics (TTRX) to Hold from Sell, according to Dow Jones Newswires, which cites Benzinga ratings data.
The same update states that the firm maintained its price target at $10.00 per share.
why it matters
Rating changes on individual stocks usually carry a narrow impact and matter mostly to investors following this company. The move reflects one analyst's updated view rather than a broader shift in the market.
tags
instruments
sources
- Turn Therapeutics Raised to Hold From Sell by WBB Securities — Dow Jones Newswires, 23 October 2026 at 11:39 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗